TALAL KHADER: Open Payments
NPI 1033314513 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,418 in 56 payments from 8 companies in 2025. Trend: 2023 $756 · 2024 $668 · 2025 $1,418
Food & beverage: $1,418
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 26 | $810 |
| Aimmune Therapeutics, Inc. | 2 | $249 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $166 |
| Novo Nordisk Inc | 3 | $62 |
| Verona Pharma, Inc. | 3 | $61 |
| Amgen Inc. | 2 | $30 |
| Viatris Specialty LLC | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
Products named: ZENPEP, CAPLYTA, AIRSUPRA, Ohtuvayre, Wegovy, OTEZLA, Ozempic, YUPELRI.
Industry payments across MI — which companies pay providers there.
